Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06419179
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-05-03
Brief Title:
Maintenance Durvalumab MEDI4736 and Olaparib AZD2281 After Standard 1st Line Treatment CarboplatinCisplatin Etoposide Durvalumab in HRD Positive Extensive Disease ED Small-cell Lung Cancer SCLC
Sponsor:
University of Cologne
Organization:
University of Cologne
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Small Cell Lung Carcinoma |
Keywords: